[go: up one dir, main page]

MX383853B - Composiciones y métodos para detectar un contaminante biológico. - Google Patents

Composiciones y métodos para detectar un contaminante biológico.

Info

Publication number
MX383853B
MX383853B MX2017012437A MX2017012437A MX383853B MX 383853 B MX383853 B MX 383853B MX 2017012437 A MX2017012437 A MX 2017012437A MX 2017012437 A MX2017012437 A MX 2017012437A MX 383853 B MX383853 B MX 383853B
Authority
MX
Mexico
Prior art keywords
compositions
methods
detecting
biological contaminant
present
Prior art date
Application number
MX2017012437A
Other languages
English (en)
Other versions
MX2017012437A (es
Inventor
Paul VESCIO
Serge Monpoeho
Sheldon Mink
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56297073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX383853(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2017012437A publication Critical patent/MX2017012437A/es
Publication of MX383853B publication Critical patent/MX383853B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a composiciones y métodos útiles para determinar si un contaminante microbiano está presente en un proceso de producción terapéutico biológico. Específicamente, se proporcionan un plásmido de control de amplificación positivo artificial y una cadena pata detección de PCR cuantitativa única, lo cual permite una detección rápida y un tiempo real de un resultado falso positivo.
MX2017012437A 2015-03-27 2016-03-25 Composiciones y métodos para detectar un contaminante biológico. MX383853B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562139321P 2015-03-27 2015-03-27
PCT/US2016/024216 WO2016160572A1 (en) 2015-03-27 2016-03-25 Compositions and methods for detecting a biological contaminant

Publications (2)

Publication Number Publication Date
MX2017012437A MX2017012437A (es) 2018-06-19
MX383853B true MX383853B (es) 2025-03-14

Family

ID=56297073

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012437A MX383853B (es) 2015-03-27 2016-03-25 Composiciones y métodos para detectar un contaminante biológico.
MX2021007667A MX2021007667A (es) 2015-03-27 2017-09-27 Composiciones y metodos para detectar un contaminante biologico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021007667A MX2021007667A (es) 2015-03-27 2017-09-27 Composiciones y metodos para detectar un contaminante biologico.

Country Status (19)

Country Link
US (3) US10669594B2 (es)
EP (3) EP3699298B1 (es)
JP (5) JP6670847B2 (es)
KR (2) KR102662675B1 (es)
CN (3) CN107960108B (es)
AR (2) AR104110A1 (es)
AU (3) AU2016243498B2 (es)
CA (2) CA2980915C (es)
DK (1) DK3274469T3 (es)
EA (2) EA202190319A1 (es)
ES (1) ES2804845T3 (es)
IL (5) IL302434B2 (es)
MX (2) MX383853B (es)
PL (1) PL3274469T3 (es)
PT (1) PT3274469T (es)
SG (2) SG10202006108RA (es)
TW (3) TWI735433B (es)
WO (1) WO2016160572A1 (es)
ZA (2) ZA201706797B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI735433B (zh) 2015-03-27 2021-08-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法
WO2018231827A1 (en) 2017-06-12 2018-12-20 Bluefin Biomedicine, Inc. Anti-il1rap antibodies and antibody drug conjugates
US20190093149A1 (en) * 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens
EP3746565A4 (en) * 2018-01-30 2021-11-03 BioFire Defense, LLC METHODS AND SYSTEMS FOR VALIDATION OF A NUCLEIC ACID AMPLIFICATION ASSAY
RU2020130821A (ru) * 2018-03-20 2022-04-20 ЛУМАСАЙТ, ЭлЭлСи Улучшенный биофизический и биохимический клеточный мониторинг и количественный анализ с использованием цитологии на основе силы лазера
EP3797163A4 (en) 2018-05-21 2022-03-09 Battelle Memorial Institute METHODS AND CONTROL COMPOSITIONS FOR SEQUENCING AND CHEMICAL ANALYZES
US11441176B2 (en) 2018-12-13 2022-09-13 Battelle Memorial Institute Methods and control compositions for a quantitative polymerase chain reaction
KR102278112B1 (ko) * 2020-07-10 2021-07-15 (주)하임바이오텍 특정 인공 뉴클레오타이드 서열을 이용한 위양성 판단용 조성물 및 이를 이용한 위양성 판단 방법
KR102532614B1 (ko) * 2020-09-18 2023-05-16 한국식품연구원 가공식품 및 농산물의 설치류 오염여부를 판별하는 방법
KR20230120136A (ko) * 2020-12-17 2023-08-16 암젠 인크 소 파보 바이러스 3 검출을 위한 실시간 pcr 방법
KR102703684B1 (ko) * 2021-07-13 2024-09-04 재단법인 바이오나노헬스가드연구단 미생물 현장 오염 검출용 조성물 및 이의 용도
CN114561492A (zh) * 2022-02-28 2022-05-31 宁夏回族自治区疾病预防控制中心(宁夏回族自治区性病艾滋病防治中心) 一种新冠病毒核酸检测阳性质控品及其制备方法和用途
WO2024137744A2 (en) * 2022-12-23 2024-06-27 Invisible Sentinel, Inc. Methods for detecting alicyclobacillus contaminants
CN116814848B (zh) * 2023-04-12 2024-03-19 中国医学科学院医学实验动物研究所 基于荧光raa检测小鼠微小病毒的引物和探针及方法
CN118531166A (zh) * 2024-07-26 2024-08-23 苏州药明检测检验有限责任公司 一种基于高通量测序技术的外源性病毒污染检测方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5585254A (en) * 1987-08-21 1996-12-17 University Of Colorado Foundation, Inc. Autonomous parvovirus gene delivery vehicles and expression vectors
US5371241A (en) 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
ATE462791T1 (de) * 1999-08-13 2010-04-15 Deutsches Krebsforsch Parvovirus ns1 varianten
AT409383B (de) 1999-12-22 2002-07-25 Baxter Ag Verfahren zur detektion und quantifizierung von nukleinsäuren in einer probe
WO2002014526A2 (en) * 2000-08-10 2002-02-21 Neurologix, Inc. Replication competent aav helper functions
US6936442B2 (en) * 2001-06-28 2005-08-30 Chiron Corporation Diagnostic assays for parvovirus B19
KR100562195B1 (ko) 2002-03-08 2006-03-20 에이에스엠엘 네델란즈 비.브이. 리소그래피용 마스크, 마스크 제조방법, 리소그래피장치및 디바이스제조방법
JP2006505275A (ja) * 2002-11-12 2006-02-16 ジェノライフ 工業製品において微生物を普遍的に検出するための一段階リアルタイムrt−pcrキット
EP1625232B1 (en) * 2003-05-16 2013-09-04 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Internal control nucleic acid molecule for nucleic acid amplification systems
NZ543855A (en) * 2003-06-05 2008-04-30 Wyeth Corp Nucleic acid arrays for detecting multiple strains of a non-viral species
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
WO2008151219A1 (en) 2007-06-04 2008-12-11 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
EP2098599A1 (en) * 2008-03-05 2009-09-09 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Composition comprising an oligonucleotide mixture for the detection of contaminations in cell cultures
WO2010111509A1 (en) * 2009-03-25 2010-09-30 Life Technologies Corporation Discriminatory positive/extraction control dna
SMT202100250T1 (it) 2009-06-26 2021-07-12 Regeneron Pharma Anticorpi bispecifici facilmente isolati con formato di immunoglobulina nativo
EP2524037B1 (en) * 2010-01-12 2018-05-16 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
JP5765790B2 (ja) * 2010-10-21 2015-08-19 ドイッチェス・クレープスフォルシュングスツェントルムDeutsches Krebsforschungszentrum ラットパルボウイルスh−1pvのそのカプシドの遺伝子操作による癌細胞への再標的化
CA2828192A1 (en) * 2011-02-25 2012-08-30 Novartis Ag Exogenous internal positive control
CN102206713B (zh) * 2011-04-06 2013-01-02 浙江大学 三重荧光定量rt-pcr检测试剂盒及用途
GB201203568D0 (en) * 2012-02-29 2012-04-11 Vela Operations Pte Ltd Real time PCR detection of streptococcus
HU230463B1 (hu) * 2012-07-02 2016-07-28 Ud-Genomed Medical Genomic Technologies Kft. Kontroll rendszer immunprecipitációs vizsgálatokhoz
SI2906235T1 (sl) * 2012-10-02 2017-12-29 Proclara Biosciences, Inc. Uporaba P3 bakteriofagnih fuzijskih proteinov kot amiloidnih vezavnih sredstev
GB2525024A (en) * 2014-04-10 2015-10-14 Vela Operations Pte Ltd Universal controls for sequencing assays
TWI735433B (zh) 2015-03-27 2021-08-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法

Also Published As

Publication number Publication date
IL316759A (en) 2025-01-01
US20230295747A1 (en) 2023-09-21
EP3699298B1 (en) 2024-04-24
ZA201806101B (en) 2020-12-23
JP2023184743A (ja) 2023-12-28
BR112017020582A2 (pt) 2018-07-17
PL3274469T3 (pl) 2020-10-05
AU2016243498B2 (en) 2022-07-07
KR20240063188A (ko) 2024-05-09
CN114875175A (zh) 2022-08-09
IL302434A (en) 2023-06-01
JP7385623B2 (ja) 2023-11-22
IL302434B1 (en) 2024-12-01
EA037740B1 (ru) 2021-05-17
IL302434B2 (en) 2025-04-01
AU2022246398A1 (en) 2022-11-03
EP3699298A1 (en) 2020-08-26
TWI735433B (zh) 2021-08-11
TW202336236A (zh) 2023-09-16
AR104110A1 (es) 2017-06-28
US20160281182A1 (en) 2016-09-29
US20200248278A1 (en) 2020-08-06
JP2020103306A (ja) 2020-07-09
SG10202006108RA (en) 2020-08-28
US10669594B2 (en) 2020-06-02
IL254731A0 (en) 2017-11-30
TWI867535B (zh) 2024-12-21
TWI804917B (zh) 2023-06-11
ES2804845T3 (es) 2021-02-09
JP6670847B2 (ja) 2020-03-25
EP3274469A1 (en) 2018-01-31
CA2980915C (en) 2024-02-27
CA3226784A1 (en) 2016-10-06
AU2022246398B2 (en) 2025-04-03
TW201706413A (zh) 2017-02-16
KR20180026661A (ko) 2018-03-13
IL281579A (en) 2021-05-31
AU2016243498A1 (en) 2017-10-26
AU2025204933A1 (en) 2025-07-17
CN114875175B (zh) 2025-04-15
CN107960108B (zh) 2022-03-08
EA202190319A1 (ru) 2021-09-30
EP4361290A3 (en) 2024-07-24
JP2021121226A (ja) 2021-08-26
EP4361290A2 (en) 2024-05-01
KR102662675B1 (ko) 2024-05-03
CN107960108A (zh) 2018-04-24
CN120249559A (zh) 2025-07-04
JP2025105635A (ja) 2025-07-10
AR119878A2 (es) 2022-01-19
PT3274469T (pt) 2020-05-29
TW202140801A (zh) 2021-11-01
EA201792155A1 (ru) 2018-04-30
WO2016160572A1 (en) 2016-10-06
IL254731B (en) 2021-04-29
JP2018509174A (ja) 2018-04-05
IL281579B (en) 2022-02-01
MX2017012437A (es) 2018-06-19
US11549154B2 (en) 2023-01-10
CA2980915A1 (en) 2016-10-06
JP6894026B2 (ja) 2021-06-23
DK3274469T3 (da) 2020-06-15
AU2016243498A2 (en) 2018-04-19
JP7669448B2 (ja) 2025-04-28
IL289447A (en) 2022-02-01
SG11201707690QA (en) 2017-10-30
MX2021007667A (es) 2021-08-05
EP3274469B1 (en) 2020-04-29
ZA201706797B (en) 2020-01-29

Similar Documents

Publication Publication Date Title
MX383853B (es) Composiciones y métodos para detectar un contaminante biológico.
CL2017002123A1 (es) Heterociclos biciclicos como inhibidores de fgnr
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
MX2017003790A (es) Detección de secuencias diana por percepción de nanoporos de sondas sintéticas.
EA201890111A1 (ru) Замещенные производные оксопиридина
MX2017009766A (es) Detección de nanoporo de polinucleótidos blanco de fondo de muestra.
MA45488A (fr) Procédés, kits et appareil de culture de cellules
BR112016016916A2 (pt) método de tratamento de angiodema hereditário (hae)
MX2017003637A (es) Derivados de fenil quinolinona como inhibidores de isocitrato deshidrogenasa mutante (mt-idh).
MA45489A (fr) Procédés de culture de cellules, kits et appareil associés
MX2017009937A (es) Cepas fungicas y metodos de uso.
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
EP3216879A4 (en) Pna probe, kit and method for detecting human papillomavirus genotype
EA201792538A1 (ru) Способ биологического получения метакриловой кислоты
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
AU2016334875A8 (en) Blood preparation and profiling
MX2017001134A (es) Composiciones y metodos para la deteccion y analisis de tuberculosis micobacteriana.
MX386087B (es) Composiciones y metodos para mejorar y/o predecir la amplificacion de adn.
PH12017501957A1 (en) Herbicide-tolerant maize plant dbn9858, and nucleotide sequence and method for detecting same
EP4407047A3 (en) Molecular detection of enterovirus and parechovirus
MX390823B (es) Metodo basado en celulas para determinar la potencia de la defibrotida.
MX371363B (es) Metodos de deteccion y cuantificacion de bacterias contenidas en o dentro de goma de mascar.
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
HK1231512A1 (zh) 檢測樣本中多種核酸的方法
MX2016015531A (es) Ensayo de inflamacion oral.